Linde, Praxair Deal Faces Regulatory Setback on Antitrust Demands

The transcript discusses the NXP deal, highlighting the FTC's late push for more concessions and the potential economic impact of additional divestitures. It explores the challenges of consolidating operations with European companies, particularly Linda, and the regulatory environment's increasing scrutiny of such deals. The discussion also touches on antitrust concerns and the political implications of job cuts associated with these mergers.

What role do job cuts and operational costs play in the concerns surrounding the NXP deal?

In what ways has the current administration's approach to regulatory scrutiny changed compared to past administrations?